Therefore, we speculated that the overexpression of SELENBP1 inhibiting the malignant progression of NSCLC cells might be connected to the inactivation of PI3K/AKT/mTOR pathway. The gene discussed is SELENBP1; the disease is non-small cell lung carcinoma.